MLV and killed preparations both have their place. Same deal for intranasal and injectible MLV products - there are instances where one is probably preferrable over the other.
Knowing how to interpret 'comparisons' between different products is sort of tricky. Remember what Mark Twain said about "lies, damned lies, and statistics"...
Unless they show the hard scientific data, anecdotal stuff like, "We've been using XXXX products for at least five years now and have seen a significant increase in reproductive efficiency", doesn't really mean anything. I could say, "I've been giving my cows castor oil for the past five years and have seen a significant increase in reproductive efficiency" - and it might be true, but it wouldn't necessarily be because of the castor oil.
'Watching who funded it' is misplaced concern, and one that I've played into in the past, but it's not valid.
Yes, drug/biologics manufacturers fund the bulk of these studies - but if they didn't, I can guarantee you that the studies/comparisons wouldn't get done, because universities don't have the $$ to do it otherwise - where else would the money come from?
But, even more importantly, those studies - and their design, results, and interpretation - are reported to and scrutinized by FDA(drugs) &/or USDA(biologics), and if things are not correct in any of those areas, the responsible agency will reject them, limit label claims - and, in some cases, require them to remove or cease & desist from making unsubstantiated claims about the efficacy of their product - and it has happened in more than one instance.
There are plenty of those studies that end up NOT showing a particular product to be significantly 'better' than another product - but they don't trumpet those results, or use them in a marketing blitz, but you could see 'em if you filed a FOI request.
For biologics(vaccines, bacterins, toxoids, etc.), USDA now has 5 label claim categories - see an article detailing those here:
http://beefmagazine.com/cowcalfweekly/u ... ne-labels/
Currently, there is only ONE cattle biologic on the market that has met the qualifications for 'prevention of infection' category - which means that 95% of animals vaccinated with it
will not become infected when challenged with field(or experimental) exposure.
There are only four licensed cattle biologics that have met the qualifications for 'prevention of disease' category (all MLV products), which means that while vaccinated animals may become infected, 90-95% will be protected from developing clinical disease, and few will require treatment.
I'm not hitting on ViraShield, but since it's already been mentioned - its label claim places it in the '
aids in prevention of disease' category, meaning that it doesn't necessarily prevent infection, but that 75-80% of animals vaccinated with it will be expected not to develop clinical disease if challenged - but that still means that as many as 25% of animals vaccinated with that product may become ill and require treatment. Now, I don't know if it's in that category because that's 'all it will do', or if they've just not yet gone to the trouble to jump through all the hoops it would require to prove to USDA that it deserves a 'higher' label claim.